Companies Clearing Cell And Gene Therapy Manufacturing Hurdles

The promise of cell and gene therapies is great, but there's a lot of work to be done between selecting a clinical candidate and eventually selling an approved product, and companies have learned that commercial scale manufacturing is a challenge that has to be addressed early on in development.

More from Anticancer

More from Therapy Areas